Key points are not available for this paper at this time.
Cytogenetic studies of germ cell tumors in prospective clinical treatment trials are warranted to define more precisely the relationship between histologic subtype, serum tumor marker production, and prognosis.
Bosl et al. (Wed,) studied this question.